Incyte appoints Dave Gardner as new chief strategy officer
PositiveFinancial Markets

Incyte has appointed Dave Gardner as its new Chief Strategy Officer, a move that signals the company's commitment to strengthening its strategic direction. Gardner brings a wealth of experience to the role, which is crucial for navigating the competitive landscape of the biopharmaceutical industry. His leadership is expected to enhance Incyte's growth and innovation efforts, making this appointment a significant step forward for the company.
— Curated by the World Pulse Now AI Editorial System